ABOUT NOT LOSSING WEIGHT ON WEGOVY

A Novo Nordisk consultant wrote within an e mail that the drugmaker anticipates “ongoing offer disruption” for the people three doses as need continues to outpace production. the corporate did not have an estimate for how long they will continue on to limit People doses. according to the progress we’ve made in setting up production capabilit